Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive Oncology
December 13, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Marc Malandro, Ph.D., to the company’s Scientific Advisory Board where he...
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
December 05, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D., (www.predictive-oncology.com) to its...
Predictive Oncology Reports Third Quarter Financial Results
November 10, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its third quarter ended September 30, 2022, which continue to...
David S. Smith appointed to the Board of Directors of Predictive Oncology
October 25, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) is pleased to announce the appointment of David S. Smith, JD, to the company’s Board of Directors. Mr. Smith is a...
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company Growth
October 20, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) is pleased to announce the appointment of Raymond F. Vennare as Chief Executive Officer and Chairman of the Board,...
Predictive Oncology Strengthens Offerings with GMP Lab and Addition of Leading Expert in Formulation Development
September 19, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced several key developments to further strengthen the company’s offerings for pharmaceutical and...
Predictive Oncology Announces CEO Retirement
September 16, 2022 17:05 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that J. Melville (“Mel”) Engle will retire as Chief Executive Officer and as Chairman and a member...
Predictive Oncology Reports Second Quarter 2022 Financial Results
August 11, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its second quarter ended June 30, 2022, which shows a strong balance...
Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm
July 26, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., July 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced a strategic move to further strengthen its business and product offerings by appointing Julia...
Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings
May 18, 2022 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., May 18, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...